Outcome of mechanical thrombectomy in the very elderly for the treatment of acute ischemic stroke: the real world experience

Chiu Yuen To, Sina Rajamand, Ratnesh Mehra, Stephanie Falatko, Yaser Badr, Boyd Richards, Omar Qahwash, Richard D Fessler, Chiu Yuen To, Sina Rajamand, Ratnesh Mehra, Stephanie Falatko, Yaser Badr, Boyd Richards, Omar Qahwash, Richard D Fessler

Abstract

Background: Although initial studies of neuroendovascular intervention did not review benefit over intravenous thrombolytics (iv r-tPA), recent studies have suggested otherwise. Elderly patients (age ≥80 years) are typically excluded from clinical trials.

Purpose: To examine the utility of mechanical thrombectomy based on patient outcomes.

Material and methods: All stroke-alert activations at our health system from January 2011 to June 2014 were examined. All patients aged ≥80 years who had undergone mechanical thrombectomy were identified. Clinical characteristics included physiologic imaging findings, use of intravenous thrombolytics, baseline and postoperative National Institute of Health Stroke Scale (NIHSS), thrombolysis in cerebral infarction scores (TICI), and discharge destination.

Results: Mean NIHSS on presentation was 18.2 (range, 6-31), and 13.3 (range, 3-30) post thrombectomy. Three (16.6%) patients received iv r-tPA, two (11.1%) had symptomatic intracranial hemorrhage. Eight (44.4%) died, eight (44.4%) were discharged to nursing homes, and two (11.7%) were discharged to inpatient rehab and subsequently home. Favorable outcome was achieved in five (27.7%) patients. Fourteen (77.7%) patients had physiologic imaging prior to intervention. Three (75%) of four patients who did not have physiologic imaging prior to thrombectomy died. Thirteen (66.6%) patients had TICI 3 recanalization.

Conclusion: Our study showed that although there remains a role of mechanical thrombectomy in the treatment of acute ischemic stroke in very elderly patients, it is associated with significant higher morbidity and mortality compared to younger patients, but should remain a very viable treatment option when quality of life is the most important consideration.

Keywords: Central nervous system (CNS); adults; brain/brain stem; ischemia/infarction; outcome analysis; thrombolysis.

References

    1. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893–903.
    1. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904–913.
    1. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11–20.
    1. Campbell BCV, Mitchell PJ, Yan B, et al. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA). Int J Stroke Off J Int Stroke Soc 2014; 9: 126–132.
    1. Hill M. Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE). Available at: .
    1. Mokin M, Dumont TM, Veznedaroglu E, et al. Solitaire FR thrombectomy for acute ischemic stroke: retrospective multicenter analysis of early postmarket experience after FDA approval. Neurosurgery 2013; 73: 19–26.
    1. Danière F, Lobotesis K, Machi P, et al. Patient selection for stroke endovascular therapy – DWI-ASPECTS thresholds should vary among age groups: insights from the RECOST study. Am J Neuroradiol 2014; 36: 32–39.
    1. Villwock MR, Singla A, Padalino DJ, et al. Acute ischaemic stroke outcomes following mechanical thrombectomy in the elderly versus their younger counterpart: a retrospective cohort study. BMJ Open 2014; 4: e004480–e004480.
    1. Bentsen L, Christensen L, Christensen A, et al. Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 2014; 23: 1944–1948.
    1. Koyanagi M, Yoshida K, Kurosaki Y, et al. Reduced cerebrovascular reserve is associated with an increased risk of postoperative ischemic lesions during carotid artery stenting. J Neurointerventional Surg 2014, pp. DOI: 10.1136/neurintsurg-2014-011163.
    1. Fessler RD, To CY, Gordon V, et al. An innovative, multidisciplinary, process-driven approach to acute stroke in a community health system network. Rev Cardiovasc Med 2014; 15: 252–265.
    1. Hassan AE, Chaudhry SA, Grigoryan M, et al. National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke J Cereb Circ 2012; 43: 3012–3017.
    1. Centers for Disease Control and Prevention. Stroke Facts. Available at: .
    1. Wilson TJ, Davis MC, Stetler WR, et al. Endovascular treatment for aneurysmal subarachnoid hemorrhage in the ninth decade of life and beyond. J Neuro interventional Surg 2014; 6: 175–177.
    1. Raoult H, Eugène F, Ferré J-C, et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol J Neuroradiol 2013; 40: 252–259.
    1. Fransen PSS, Beumer D, Berkhemer OA, et al. MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial. Trials 2014; 15: 343–343.
    1. Bagg S, Pombo AP, Hopman W. Effect of age on functional outcomes after stroke rehabilitation. Stroke 2002; 33: 179–185.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe